|Hepatitis C prevention efforts under way|
Kwiatkowski's contract wasn't extended, but he went on to work in nine more hospitals in five states, stealing drugs and infecting patients with hepatitis C through tainted syringes along the way. The criminal case against him ended last week when he ...
Exeter News-Letter - Thu, 12 Dec 2013 22:56
|Surviving Hepatitis C|
“I was diagnosed with Hepatitis C. There was no medicine I can give you for treatment. You are ultimately going to die,” says Darla. Not one to take the information with a whimper, Darla did her own research. She volunteered for clinical trials ...
KOLO - Thu, 12 Dec 2013 17:52
|Hepatitis C case prompts safety fixes|
Kwiatkowski's contract wasn't extended, but he went on to work in nine more hospitals in five states, stealing drugs and infecting patients with hepatitis C through tainted syringes along the way. The criminal case against the former Exeter Hospital ...
Seacoastonline.com - Wed, 11 Dec 2013 01:00
|Hepatitis C patients with fibrosis have more complications after TJA|
Patients with hepatitis C patients perform similarly to control patients after elective total joint arthroplasty. However, patients with hepatic fibrosis have greater infection rates and patients with thrombocytopenia experienced more complications ...
Healio - Thu, 12 Dec 2013 08:30
|FDA Approves Hepatitis C Pill|
"Today's approval represents a significant shift in the treatment paradigm for some patients with chronic hepatitis C," said Dr. Edward Cox, director of the FDA's office of antimicrobial products. The greater convenience and effectiveness of the pill ...
Latin Post - Thu, 12 Dec 2013 12:36
|Gilead Sciences, Inc. (NASDAQ:GILD) Maintains Its Dominance|
FinancialsTrend - Thu, 12 Dec 2013 03:48
|Gilead Sciences, Inc. (GILD)'s Sofosbuvir Gains FDA Approval, Attracts Patent ...|
Next iPhone News - Wed, 11 Dec 2013 05:41
|Gilead's Sofosbuvir Gets New Name, Price, Headaches|
Motley Fool - Wed, 11 Dec 2013 13:11
|3 Large Cap Healthcare Stocks That Belong in Your Portfolio|
Wall St. Cheat Sheet - Thu, 12 Dec 2013 06:26
|Rumor Could Give Traders Another Shot at a Top Biotech|
Investorplace.com - Tue, 10 Dec 2013 22:33
|HealthStat Rx: Curing Hepatitis C (HCV) With Confidence|
ATLANTA, Dec 12, 2013 (BUSINESS WIRE) -- One of the nation's leading medication therapy management companies, HealthStat Rx, announces today it offers Sovaldi(TM) from Gilead Sciences and Olysio(TM) from Janssen Therapeutics, to treat chronic ...
MarketWatch - Thu, 12 Dec 2013 07:09
|New weapon to cure Hepatitis C|
KANSAS CITY, Mo. — Hepatitis C is a liver-destroying virus that's most common in baby boomers. Many got it years ago from IV drug use or unsafe sex. Now there's a new drug to cure it. Four years ago, a physical brought bad news for Bill Barber. He had ...
fox4kc.com - Thu, 12 Dec 2013 18:36
|AbbVie oral hep C drugs cure 96 percent in late stage trial|
(Reuters) - AbbVie Inc's all-oral hepatitis C therapy cured 96 percent of difficult-to-treat patients in a late-stage clinical trial after 12 weeks, keeping the company well placed in a highly competitive race to deliver new treatments for the serious ...
Chicago Tribune - Tue, 10 Dec 2013 05:43